Turm des Monats

In der Rubrik "Turm des Monats" finden die Besucher der Turm Rietberg-Seiten Anregungen rund ums Thema Schach: Das können lohnende Bücher und Trainings-DVDs sein, aber auch interessante Internet-Seiten oder Hinweise auf spannende Turniere. Die Tipps erheben keinen Anspruch auf Vollstandigkeit und wollen das Rad (bzw. das Schachquadrat) nicht neu erfinden, sondern Anstöße und Anreize geben. Jedes Vereinsmitglied ist außerdem eingeladen, die "Türme" zu kommentieren und (an den Vereinsabenden oder per Mail) eigene » einzusenden.

Schach in der Musik – Alan Parsons Project

Ich habe mal wieder etwas in den Archiven meiner Lieblingsinterpreten gestöbert und stieß dabei auf ein Werk, das vom Schachspiel inspiriert wurde: "The Sicilian Defence" von Alan Parsons Project, deren Debut-Album "Tales of Mystery and Imagination" wahrscheinlich die meisten kennen. Fernsehzuschauern ist sicher auch der Titel "Lucifer" vom Album Eve bekannt. Dieses Stück ist seit 1990 die Erkennungsmelodie der Sendung Monitor im WDR.

The Sicilian Defence ist das zwölfte (und letzte) Studioalbum von Alan Parsons Project. Es wurde im Jahr 2014 veröffentlicht aber bereits 1979 aufgenommen. Es besteht aus 10 Titeln, die jeweils den Namen eines Schachzugs der Sizilianischen Verteidigung haben. Sie sind aber nicht in der üblichen algebraischen Notation, sondern in der etwas aus der Mode gekommenen beschreibenden Notation. Diese war in den angelsächsischen Ländern bis in die 1980er Jahre üblich und stark verbreitet.

1. "P-K4"
2. "P-QB4
3. "Kt-KB3"
4. "...Kt-QB3"
5. "P-Q4"
6. "PxP"
7. "KtxP"
8. "Kt-B3"
9. "Kt-QB3"
10. "P-Q3"

Das entspricht dem klassischen Sizilianer:

1. e4 c5
2. Sf3 Sc6
3. d4 cxd4
4. Sxd4 Sf6
5. Sc3 d6

(Ein musikalisches Eröffnungsbuch)

Link: » Wer sich näher über die Beschreibende Notation informieren möchte findet natürlich etwas darüber auf Wikipedia. Man beachte das Partieformular von Bobby Fischer.

Das Album entstand, weil die Musiker ihrem Label noch ein Werk schuldeten und ist sicher nicht das Beste was die Band zu bieten hat. Ob Alan Parsons und Eric Woolfson Schach spielten ist zu vermuten, es liegen mir aber keine Belege dafür vor. Alan Parsons veröffentlichte 2019 sein bisher letztes Album, Eric Woolfson verstarb im Jahre 2009.

Link: » Weitere Infos zum Alan Parsons Project findet ihr auf Wikipedia.

Link: » Weitere Infos zum Album The Sicillian Defence auf Wikipedia (englisch)

Wer mag kann sich das Werk hier anhören : Link: » The Sicilian Defence auf YouTube


(E.A.)

Alle Türme

• CJC?1295 and ipamorelin are two peptides that have gained attention for their
  potential to stimulate growth hormone release in clinical and non?clinical settings.
  
  While they share a common goal of enhancing anabolic processes, users
  often report a range of side effects that can vary from
  mild to more pronounced. Understanding these adverse reactions is essential for anyone considering
  or currently using these compounds. Below is an extensive overview of the documented side effects, contextualized within broader research findings
  and compared to other growth?modulating agents such as azathioprine, which is administered orally.
  
  
  
  
  Side Effect Profile of CJC?1295 and Ipamorelin
  
  
  
  Common mild reactions
  Patients frequently describe a feeling of fullness
  or mild swelling at the injection site. This local irritation can be
  accompanied by slight redness that usually resolves within a day or two.
  Some users also note transient headaches or a mild sense of fatigue, especially during the
  first few weeks of therapy.
  
  
  
  Hormonal imbalances
  Because CJC?1295 and ipamorelin stimulate growth hormone
  secretion, they may inadvertently increase insulin?like growth factor 1 (IGF?1)
  levels. Elevated IGF?1 can lead to water retention, causing mild edema in extremities or the face.
  
  In rare cases, increased IGF?1 has been linked to a rise
  in blood pressure and occasional palpitations.
  
  
  
  
  Metabolic effects
  Growth hormone excess can influence glucose metabolism.
  A subset of users experience subtle changes in fasting glucose levels, sometimes necessitating closer monitoring for
  those with preexisting insulin resistance or type
  2 diabetes. While the majority do not develop significant hyperglycemia,
  the potential exists, particularly when doses are escalated beyond recommended ranges.
  
  
  
  
  Psychological impact
  Some individuals report mood swings or a temporary decrease in motivation during early
  treatment phases. These changes often subside after adaptation to altered hormone
  levels but may require counseling if they persist.
  
  
  
  Serious but rare events
  Severe allergic reactions, such as anaphylaxis, have been documented in isolated cases.
  Additionally, there is anecdotal evidence suggesting that
  long?term use might influence thyroid function or
  provoke mild thyroiditis. Although these occurrences are uncommon,
  they underscore the importance of periodic endocrine
  evaluations during extended therapy.
  
  
  
  Research and Clinical Trials
  
  
  
  The majority of side effect data originates from
  small?scale human trials and animal studies conducted between 2010 and 2023.
  In a randomized, double?blind study involving thirty healthy volunteers, researchers observed mild injection site reactions in twenty?five percent of participants.
  No serious adverse events were recorded over the twelve?week
  observation period. Another phase I trial with ten subjects focused on pharmacokinetics and found transient increases in IGF?1 without clinically relevant changes in glucose or lipid
  profiles.
  
  
  
  Animal research has shed light on potential long?term effects.
  In a longitudinal study of mice receiving daily doses equivalent
  to human therapeutic levels, researchers noted no significant
  organ toxicity over a six?month period. However, they did
  observe subtle alterations in liver enzyme activity and an increased incidence of mild hepatic steatosis in the highest dose group.
  
  
  
  
  Regulatory Status and US Brand Names
  
  
  
  In the United States, both CJC?1295 and ipamorelin are classified as investigational peptides.
  
  They have not received approval from the Food and Drug Administration for
  therapeutic use outside of clinical trials. Consequently,
  there is no official brand name available for these compounds in U.S.
  markets. Researchers typically purchase them through specialized compounding pharmacies
  or academic suppliers under research protocols.
  
  
  
  
  Comparison with Azathioprine (oral route)
  
  
  
  Azathioprine is an immunosuppressive drug widely used to prevent organ transplant rejection and
  treat autoimmune disorders. Unlike the growth hormone–stimulating peptides,
  azathioprine’s mechanism involves inhibiting purine synthesis, thereby reducing lymphocyte proliferation. Its oral administration leads to a
  distinct side effect profile:
  
  
  
  Common adverse effects
  Nausea, vomiting, abdominal pain, and diarrhea are frequently
  reported, especially when doses exceed 2
  mg/kg/day. Hematologic toxicity is also common; patients may develop leukopenia or anemia due to bone marrow suppression.
  
  
  
  Long?term risks
  Chronic use raises the risk of hepatotoxicity, which can manifest as elevated liver enzymes or fulminant hepatic failure in rare cases.
  There is also an increased incidence of infections and a heightened risk for certain cancers, particularly lymphoma and skin malignancies.
  
  
  
  
  Research context
  Large cohort studies have documented these effects
  over decades of clinical practice. Unlike CJC?1295 and ipamorelin, azathioprine’s safety data are robust, given its widespread use
  in transplant medicine. This extensive evidence base informs dose adjustments and monitoring protocols,
  such as regular complete blood counts and liver function tests.
  
  
  
  
  In summary, while CJC?1295 and ipamorelin offer promising anabolic benefits, their side effect profile—ranging from mild local reactions to potential metabolic disturbances—requires careful monitoring.
  The absence of FDA approval and limited long?term data emphasize the need for clinical vigilance.
  
  In contrast, azathioprine’s well?established safety data highlight how extensive research can shape treatment guidelines
  for immunosuppressive agents administered orally.

  schrieb valley md am 08.10.2025

• quatro casino canada, free pokies 4u canada and casino in united states,
  or free poker machines online united states

  schrieb Micaela am 08.10.2025

• Do you have any video of that? I'd care to find out some additional information.

  schrieb Birmingham escorts am 08.10.2025

• best place to buy real steroids online
  
  References: <br />
  
  https://ryanwhittingham.com/git/oosbreanna4822 <br />

  schrieb ryanwhittingham.com am 08.10.2025

• Well expressed of course. !

  schrieb legal am 08.10.2025

Kommentar hinterlassen

Name
Email (optional)
URL (optional)

AntiSpam Die Summe aus 5 + 2 =